TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
FATE

Fate Therapeutics Inc

Healthcare · Biotechnology

2.50$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Fate Therapeutics Inc (FATE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -106 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow FATE
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-22 -18 -30 -37 -39 -83 -39 -163 -248 -132 -123 -106
0.5 0.7 0.9 1.0 1.2 2.2 3.1 5.9 14 18 19 9.3
2.4 2.4 3.2 3.6 6.3 17 31 54 79 43 41 25
2.6 3.0 3.7 5.0 6.9 17 31 37 52
0.0 0.4 1.2 2.1 1.7 3.6 -13 2.1 -35 19 -2.0 -3.7
0.9 1.5 0.5 1.7 2.3 7.4 4.9 51 36 6.2 0.7 6.0
-0.9 -1.5 -4.1 -10 -0.5 -157 -161 -324 167 113 12 111
0.0 0.4 0.2 15 2.5
0.1 0.4 0.2 -0.2 2.7 2.5 248 432
18 -1.5 -7.7 4.2 -15 -15 0.0
18 36 58 47 141 150 283 453 9.2 0.1 100 5.5
-4.9 16 24 0.3 102 -91 68 -34 -72 -19 -5.8 11
-23 -20 -30 -39 -41 -91 -44 -214 -284 -138 -124 -112

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?